Page 4 - Amy Wolf News Today

REGULATED INFORMATION  Description of the regulatory framework of the share repurchase programproposed by the Board of Directors to be approved at theCombined Shareholders’ Meeting... | May 31, 2023

REGULATED INFORMATION  COMBINED SHAREHOLDERS’ MEETING OF IPSEN S.A.HELD ON 31 MAY 2023 ALL THE RESOLUTIONS SUBMITTED TO THE SHAREHOLDERS’ VOTE HAVE BEEN APPROVED Paris , 31 May... | May 31, 2023

Palovarotene is the first medicine to be submitted for regulatory approval for fibrodysplasia ossificans progressiva , an ultra-rare disease with an estimated prevalence of 1.36 per million... | May 26, 2023

Palovarotene is the first medicine to be submitted for regulatory approval for fibrodysplasia ossificans progressiva (FOP), an ultra-rare disease with an estimated prevalence of 1.36 per million individuals

Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic liver diseasesNew data emphasizes the consistent benefit of Bylvay as an... | May 17, 2023

Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic liver diseasesNew data emphasizes the consistent benefit of Bylvay as an investigational

Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance Paris , 27 April 2023Ipsen , a global specialty-driven biopharmaceutical company,... | April 27, 2023

            PRESS RELEASE Regulated Information Ipsen publishes its 2022 Universal Registration Document Paris (France), 6 April...

            PRESS RELEASE Regulated Information Ipsen publishes its 2022 Universal Registration Document Paris , 6 April 2023 – Ipsen... | April 6, 2023

A board that supervises Venezuela's overseas assets said it plans to file an appeal to a U.S. court's decision granting four firms the right to seize shares in one of the parent companies of Venezuela-owned U.S. refiner Citgo Petroleum.